The interplay between HPV and host immunity in head and neck squamous cell carcinoma (Q38126455)

29 August 2017

title

The interplay between HPV and host immunity in head and neck squamous cell carcinoma (English)

1 reference

29 August 2017

Anne Skou Andersen

1

1 reference

29 August 2017

Anne Sophie Koldjaer Sølling

series ordinal

2

1 reference

29 August 2017

Therese Ovesen

series ordinal

3

1 reference

29 August 2017

Maria Rusan

series ordinal

4

1 reference

29 August 2017

language of work or name

English

0 references

publication date

29 August 2013

1 reference

International Journal of Cancer

29 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 August 2017

volume

134

1 reference

29 August 2017

issue

12

1 reference

29 August 2017

page(s)

2755-2763

1 reference

Human papillomavirus and survival of patients with oropharyngeal cancer.

29 August 2017

cites work

1 reference

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

21 January 2018

1 reference

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.

21 January 2018

1 reference

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis

21 January 2018

1 reference

Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study

21 January 2018

1 reference

Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer

21 January 2018

1 reference

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

21 January 2018

1 reference

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

21 January 2018

1 reference

The biology and life-cycle of human papillomaviruses.

21 January 2018

1 reference

Productive Lifecycle of Human Papillomaviruses that Depends Upon Squamous Epithelial Differentiation

21 January 2018

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer

21 January 2018

1 reference

MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome

21 January 2018

1 reference

Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer

21 January 2018

1 reference

Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients

21 January 2018

1 reference

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma

21 January 2018

1 reference

Global burden of human papillomavirus and related diseases.

21 January 2018

1 reference

Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis

21 January 2018

1 reference

Molecular epidemiology of human papillomavirus

21 January 2018

1 reference

Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity

21 January 2018

1 reference

Molecular biology of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

Molecular mechanisms of human papillomavirus-induced carcinogenesis.

21 January 2018

1 reference

Pathology and epidemiology of HPV infection in females

21 January 2018

1 reference

Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.

21 January 2018

1 reference

Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers

21 January 2018

1 reference

The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer

21 January 2018

1 reference

Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3alpha production

21 January 2018

1 reference

Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein

21 January 2018

1 reference

Human papillomavirus can escape immune recognition through Langerhans cell phosphoinositide 3-kinase activation

21 January 2018

1 reference

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

21 January 2018

1 reference

The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon-alpha

21 January 2018

1 reference

Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis

21 January 2018

1 reference

E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I.

21 January 2018

1 reference

HPV - immune response to infection and vaccination

21 January 2018

1 reference

Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study.

21 January 2018

1 reference

Human papillomavirus vaccines--immune responses

21 January 2018

1 reference

Morphology and immunology of the human palatine tonsil

21 January 2018

1 reference

HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation.

21 January 2018

1 reference

Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma

21 January 2018

1 reference

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

21 January 2018

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

Adaptive immunity maintains occult cancer in an equilibrium state

21 January 2018

1 reference

Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression

21 January 2018

1 reference

Expression of tumour-specific antigens underlies cancer immunoediting

21 January 2018

1 reference

Maintenance of CD8 effector T cells by CD4 helper T cells eradicates growing tumors and promotes long-term tumor immunity.

21 January 2018

1 reference

Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer

21 January 2018

1 reference

Cancer risk in people infected with human immunodeficiency virus in the United States

21 January 2018

1 reference

Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management

21 January 2018

1 reference

Warts and all: human papillomavirus in primary immunodeficiencies

21 January 2018

1 reference

Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus

21 January 2018

1 reference

Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients

21 January 2018

1 reference

Cervical and anal HPV infections in HIV positive women and men.

21 January 2018

1 reference

Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

21 January 2018

1 reference

Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.

21 January 2018

1 reference

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

21 January 2018

1 reference

Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

21 January 2018

1 reference

21 January 2018

Inflammation and cancer

1 reference

Inflammatory chemokines in cancer growth and progression

21 January 2018

1 reference

IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

21 January 2018

1 reference

NF-kappaB functions as a tumour promoter in inflammation-associated cancer

21 January 2018

1 reference

T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynx

21 January 2018

1 reference

Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium

21 January 2018

1 reference

Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3

21 January 2018

1 reference

Human papilloma virus specific T cells infiltrating cervical cancer and draining lymph nodes show remarkably frequent use of HLA-DQ and -DP as a restriction element.

21 January 2018

1 reference

T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.

21 January 2018

1 reference

Tonsil T cell immunity to human papillomavirus in the absence of detectable virus in healthy adults

21 January 2018

1 reference

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck

21 January 2018

1 reference

HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

21 January 2018

1 reference

Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport

21 January 2018

1 reference

A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions

21 January 2018

1 reference

Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection

21 January 2018

1 reference

Recurrent respiratory papillomatosis: altered CD8(+) T-cell subsets and T(H)1/T(H)2 cytokine imbalance.

21 January 2018

1 reference

Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia

21 January 2018

1 reference

Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer

21 January 2018

1 reference

Biomarkers of HPV in head and neck squamous cell carcinoma.

21 January 2018

1 reference

Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review

21 January 2018

1 reference

Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer.

21 January 2018

1 reference

Profiling of immune response to guide cancer diagnosis, prognosis, and prediction of therapy.

21 January 2018

1 reference

Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis.

21 January 2018

1 reference

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

21 January 2018

1 reference

The mutational landscape of head and neck squamous cell carcinoma

21 January 2018

1 reference

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

Immunotherapy of head and neck cancer: current and future considerations

21 January 2018

1 reference

Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28411

1 reference

29 August 2017

1 reference